Biosurfit S.A., Epistem, Qlucore AB, French National Institute of Health and Medical Research (INSERM), Inserm Transfert Initiative diagnostics news

Epistem said it received a three-year €1.5 million ($2 million) award from the EU's Framework Programme 7 (FP7) as part of a €6 million ($8 million) award for the PoC-HCV consortium project to develop...